Results 31 to 40 of about 9,225,670 (325)
Frontiers in Immunology, 2017 Several lines of evidence suggest a definite and unique link between CNS demyelinating diseases and autoimmune thyroid disease (AITD). The aim of the current study was to systematically compare the clinical and laboratory features of patients with ...
Judith M. Greer +4 more
doaj +1 more source
Journal of Clinical Pathology, 2006 A diagnosis of demyelination carries important therapeutic and prognostic implications. In most cases the diagnosis is made clinically, and involvement of the histopathologist is largely confined to postmortem confirmation and clinicopathological correlation.
openaire +3 more sources
Parkinsonism and neurosarcoidosis: Cause and effect or coincidence?
Clinical Parkinsonism & Related Disorders, 2019 Movement disorders in demyelinating diseases can be coincidental or secondary to a demyelinating lesion. We here report the first case of coincidental association of neurosarcoidosis and idiopathic Parkinson's disease.
Raja Mehanna, Lael Stone, Ilia Itin
doaj +1 more source
Clinical utility of a molecular signature in inflammatory demyelinating disease
Neurology: Neuroimmunology & Neuroinflammation, 2018 Objective We sought to develop molecular biomarkers of intrathecal inflammation to assist neurologists in identifying patients most likely to benefit from a range of immune therapies.
A. Pachner +3 more
semanticscholar +1 more source
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Therapeutic Advances in Neurological Disorders, 2018 Extensive research over the last decades basically failed to identify a common cause of noninfectious inflammatory central nervous system (CNS) demyelinating disease.
Martin S. Weber +3 more
doaj +1 more source
Cancer Medicine, 2023 Background Distinguishing between central nervous system lymphoma (CNSL) and CNS infectious and/or demyelinating diseases, although clinically important, is sometimes difficult even using imaging strategies and conventional cerebrospinal fluid (CSF ...
Chisako Iriyama +18 more
doaj +1 more source
Clinical Chemistry and Laboratory Medicine, 2018 Background: Cerebrospinal fluid (CSF) used in immunoglobulin gamma (IgG) index testing and oligoclonal bands (OCBs) are common laboratory tests used in the diagnosis of multiple sclerosis.
Kari M. Gurtner +6 more
semanticscholar +1 more source
Asymmetric Type F Botulism with Cranial Nerve Demyelination
Emerging Infectious Diseases, 2012 We report a case of type F botulism in a patient with bilateral but asymmetric neurologic deficits. Cranial nerve demyelination was found during autopsy. Bilateral, asymmetric clinical signs, although rare, do not rule out botulism.
Alina Filozov +6 more
doaj +1 more source
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
Journal of Neuroinflammation, 2017 BackgroundMultiple sclerosis is a neuroinflammatory demyelinating and neurodegenerative disease of the central nervous system characterized by recurrent and progressive demyelination/remyelination cycles, neuroinflammation, oligodendrocyte loss ...
Shinji Yamamoto +8 more
semanticscholar +1 more source
Fulminant Demyelinating Diseases [PDF]
The Neurohospitalist, 2013 Fulminant demyelinating disease is a heading that covers acute disseminated encephalomyelitis and its variant acute hemorrhagic leukoencephalitis (Hurst disease), severe relapses of multiple sclerosis (MS), variants of MS (tumefactive MS, Marburg variant, Balo concentric sclerosis, myelinoclastic diffuse sclerosis), and neuromyelitis optica-spectrum ...
Orhun H. Kantarci, Megan R. Rahmlow
openaire +3 more sources